115 results on '"Mihai, Catalina"'
Search Results
2. Evaluation of Disease Activity in Inflammatory Bowel Disease: Diagnostic Tools in the Assessment of Histological Healing
3. Gastro-Esophageal Reflux Disease and Paroxysmal Atrial Fibrillation Ablation
4. Diagnosis of minimal hepatic encephalopathy in a tertiary care center from eastern Romania: validation of the psychometric hepatic encephalopathy score (PHES)
5. Specific features of clostridium difficile colitis in patients with inflammatory bowel disease
6. Rollover as a Gait in Legged Autonomous Robots: A Systems Analysis.
7. Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older
8. Current aspects with regard to the link between pregnancy and inflammatory bowel disease
9. The risks of hepatocellular carcinoma and variceal bleeding after HCV eradication with direct-acting antiviral therapy: a propensity score analysis
10. Romanian Guidelines for the Diagnosis and Treatment of GERD-induced Respiratory Manifestations
11. Role of PNPLA3 in the Assessment and Monitoring of Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C Infection Who Achieved a Sustained Virologic Response
12. New onset severe ulcerative colitis following Ixekizumab therapy.
13. Gastrointestinal stromal tumor
14. Effectiveness of 8- and 12-Week Treatment with Ombitasvir/ Paritaprevir/Ritonavir and Dasabuvir in Treatment-Naïve HCV Patients in a Real-Life Setting in Romania: the AMETHYST Study
15. Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis
16. A Machine Learning Model Accurately Predicts Ulcerative Colitis Activity at One Year in Patients Treated with Anti-Tumour Necrosis Factor α Agents
17. Forrest III duodenal ulcers during treatment with adalimumab for psoriasis
18. Terahertz Spectroscopy and Imaging: A Cutting-Edge Method for Diagnosing Digestive Cancers
19. Pancreatico-Pleural Fistula – from Diagnosis to Management. A Case Report
20. Advanced Image Processing in Support of THz Imaging for Early Detection of Gastric Cancer
21. Developing a Neural Network Model for a Non-invasive Prediction of Histologic Activity in Inflammatory Bowel Diseases.
22. The specialized educational and psychological counseling in inflammatory bowel disease patients - a target or a challenge?
23. The Role of Combining Biochemical Markers in Assessing the Endoscopic Activity in Ulcerative Colitis
24. Correlations Between Inflammatory Biomarkers and Activity in Inflammatory Bowel Diseases
25. Cultural resilience or the Interethnic Dobrujan Model as a Black Sea alternative to EuroIslam in the Romanian Turkish-Tatar community
26. Metabolic Syndrome and Genotype 1 Virus C Compensated Liver Cirrhosis in the Era of Directly Acting Antiviral Therapy
27. Alpha Fetoprotein and a Useful Tool for Surveillance of Interferon-Free Treated Cirrhotic Patients for Hepatocellular Carcinoma After SVR
28. Predictors of Liver Stiffness Regression after SVR in Cirrhotic Patients Treated with 3D Regimen
29. A Low Incidence of Hepatocellular Carcinoma in Patients with Genotype 1B Compensated Cirrhosis Treated with Paritaprevir/Ritonavir, Ombitasvir and Dasabuvir  ± Ribavirin in a Tertiary Center: A Matter of Better Selection?
30. Efficacy and Safety of Paritaprevir/Ritonavir, Ombitasvir and Dasabuvir Plus/Minus Ribavirin for Treatment of HCV Genotype 1B Compensated Cirrhosis in Patients Aged 70 Years or Older
31. Prospective Analysis of Discordant Results Between Fibromax® and Fibroscan® in Patients with HCV Compensated Liver Cirrhosis before 3D Antiviral Therapy Initiation
32. Bone mineral metabolism, bone mineral density in patients with chronic pancreatitis
33. Obesity, risk factor for severe acute pancreatitis
34. Clinical efficacity of ocreotide in acute pancreatitis
35. Rollover as a Gait in Legged Autonomous Robots: A Systems Analysis
36. Sa1540 - Prospective Analysis of Discordant Results Between Fibromax® and Fibroscan® in Patients with HCV Compensated Liver Cirrhosis before 3D Antiviral Therapy Initiation
37. Tu1540 - A Low Incidence of Hepatocellular Carcinoma in Patients with Genotype 1B Compensated Cirrhosis Treated with Paritaprevir/Ritonavir, Ombitasvir and Dasabuvir ± Ribavirin in a Tertiary Center: A Matter of Better Selection?
38. Tu1541 - Efficacy and Safety of Paritaprevir/Ritonavir, Ombitasvir and Dasabuvir Plus/Minus Ribavirin for Treatment of HCV Genotype 1B Compensated Cirrhosis in Patients Aged 70 Years or Older
39. Tu1544 - Predictors of Liver Stiffness Regression after SVR in Cirrhotic Patients Treated with 3D Regimen
40. Sa1465 - Alpha Fetoprotein and a Useful Tool for Surveillance of Interferon-Free Treated Cirrhotic Patients for Hepatocellular Carcinoma After SVR
41. PARADOXICAL CROHN'S DISEASE - MYTH OR REALITY?
42. Su1077 Vitamin D and B12 Supplementation and Sustained Virologic Response in Chronic Hepatitis C Patients Treated With Pegylated Interferon and Ribavirin
43. Is Rifaximin Effective in Maintaining Remission in Crohn's Disease?
44. Tu1053 The Value of Contrast Enhanced Ultrasound (CEUS) for Focal Liver Lesions Characterization - A Multicenter Romanian Study
45. PROBIOTICELE ŞI PATOLOGIA CHIRURGICALĂ. OPŢIUNE SUBEVALUATĂ?
46. A rapid test for assessing disease activity in ulcerative colitis.
47. The Value of Contrast Enhanced Ultrasound (CEUS) for Focal Liver Lesions Characterization - A Multicenter Romanian Study
48. The influence of clinical significant portal hypertension (stage Baveno 2) on safety, tolerability and efficacy of paritaprevir, ritonavir, ombitasvir, dasabuvir and ribavirin (PrOD plus R) in a real-world large cohort of genotype 1b HCV liver cirrhosis patients
49. ARTICULAR INVOLVEMENT IN INFLAMMATORY BOWEL DISEASE - THE MOST FREQUENT EXTRAINTESTINAL MANIFESTATION.
50. DISEASE IMPACT ON QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE VERSUS IRRITABLE BOWEL SYNDROME.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.